Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lanman Spinal Neurosurgery has pioneered Restorative Motion Surgery (reversal of spinal fusions with artificial disc implantation) and consistently leads or participates in US clinical trials for novel artificial disc technologies, including prodisc C Vivo, prodisc SK, Synergy Disc, and innovative lumbar joint devices, contributing to FDA approvals and technological advancement in motion preservation
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lanman Spinal Neurosurgery.